Lantern Pharma(LTRN) - 2024 Q1 - Quarterly Results

Exhibit 99.1 Lantern Pharma Reports First Quarter 2024 Financial Results and Business Highlights Thursday, May 9, 2024 DALLAS — (Business Wire) — Lantern Pharma Inc. (NASDAQ: LTRN), an artificial intelligence ("AI") company developing targeted and transformative cancer therapies using its proprietary RADR AI and machine learning ("ML") platform with multiple clinical-stage drug programs, today announced operational highlights and financial results for the first quarter 2024, ended March 31, 2024. "Our compa ...